We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.13B
AUM Growth
-$2.03B
Cap. Flow
+$382B
Cap. Flow %
4,191.08%
Top 10 Hldgs %
16.25%
Holding
592
New
147
Increased
69
Reduced
127
Closed
192

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$185M
2
MRVL icon
Marvell Technology
MRVL
+$135M
3
LOGM
LogMein, Inc.
LOGM
+$110M
4
CA
CA, Inc.
CA
+$96.6M
5
HON icon
Honeywell
HON
+$85.8M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$201M
2
PANW icon
Palo Alto Networks
PANW
+$144M
3
GM icon
General Motors
GM
+$119M
4
COST icon
Costco
COST
+$111M
5
BDX icon
Becton Dickinson
BDX
+$104M

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Industrials 17.44%
3 Financials 11.93%
4 Healthcare 11.85%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
401
Aclaris Therapeutics
ACRS
$869M
– –
-613,635
Closed -$12.3M
ADI icon
402
Analog Devices
ADI
$190B
– –
-1,062,872
Closed -$102M
AKBA icon
403
Akebia Therapeutics
AKBA
$252M
– –
-97,734
Closed -$975K
AM icon
404
Antero Midstream
AM
$10.1B
– –
-2,100,000
Closed -$39.6M
AR icon
405
Antero Resources
AR
$10.7B
– –
-812,987
Closed -$17.4M
ARDX icon
406
Ardelyx
ARDX
$997M
– –
-146,666
Closed -$543K
ATXS
407
DELISTED
Astria Therapeutics
ATXS
– –
-18,692
Closed -$840K
AUPH icon
408
Aurinia Pharmaceuticals
AUPH
$2.11B
– –
-188,709
Closed -$1.06M
AWI icon
409
Armstrong World Industries
AWI
$7.84B
– –
-20,466
Closed -$1.29M
DCH
410
Dauch Corp
DCH
$1.51B
– –
-443,650
Closed -$6.9M
BAX icon
411
Baxter International
BAX
$14.2B
– –
-420,217
Closed -$31M
BBY icon
412
Best Buy
BBY
$17.3B
– –
-251,965
Closed -$18.8M
BDX icon
413
Becton Dickinson
BDX
$48.2B
– –
-447,064
Closed -$104M
BFH icon
414
Bread Financial
BFH
$4.38B
– –
-6,433
Closed -$1.2M
BLUE
415
DELISTED
bluebird bio
BLUE
– –
-5,071
Closed -$10.3M
BPMC
416
DELISTED
Blueprint Medicines
BPMC
– –
-119,758
Closed -$7.6M
CDLX icon
417
Cardlytics
CDLX
$21.5M
– –
-2,199
Closed -$478K
CDTX
418
DELISTED
Cidara Therapeutics
CDTX
– –
-4,628
Closed -$481K
CGBD icon
419
Carlyle Secured Lending
CGBD
$758M
– –
-133,980
Closed -$2.28M
CHRW icon
420
C.H. Robinson
CHRW
$17.5B
– –
-91,254
Closed -$7.63M
CNQ icon
421
Canadian Natural Resources
CNQ
$93.8B
– –
-1,282,043
Closed -$22.6M
VISN
422
Vistance Networks Inc
VISN
$2.52B
– –
-264,477
Closed -$7.72M
COR icon
423
Cencora
COR
$61.2B
– –
-13,044
Closed -$1.11M
CRM icon
424
Salesforce
CRM
$158B
– –
-387,101
Closed -$52.8M
CSCO icon
425
Cisco
CSCO
$479B
– –
-2,356,639
Closed -$101M
15 16
17
18 19

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2018 Portfolio in Review

As of Q3 2018, Alyeska Investment Group held 592 positions worth $9.13B, down 18% from $11.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $382B of net new capital in Q3 2018, opening 147 new positions and adding to 69 existing holdings. Its largest new stake was Marvell Technology: 6,576,490 shares worth $127M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $144M trimmed.

  • Alyeska Investment Group's largest Q3 2018 buy was Marvell Technology: 6,576,490 shares worth $127M.
  • Alyeska Investment Group added most to Electronic Arts in Q3 2018, an estimated $185M increase.
  • Alyeska Investment Group's biggest Q3 2018 reduction was Palo Alto Networks, cutting an estimated $144M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q3 2018, selling an estimated $201M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $9.13B portfolio in Q3 2018.
  • Alyeska Investment Group opened 147 new positions and closed 192 in Q3 2018.
  • Alyeska Investment Group's portfolio value fell 18% quarter-over-quarter to $9.13B.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.